Literature DB >> 21090187

A new national Chlamydia Sentinel Surveillance System in Australia: evaluation of the first stage of implementation.

Rebecca J Guy1, Fabian Kong, Jane Goller, Neil Franklin, Isabel Bergeri, Wayne Dimech, Nicole Reilly, Elizabeth Sullivan, James Ward, John M Kaldor, Margaret Hellard, Basil Donovan.   

Abstract

The Australian Collaboration for Chlamydia Enhanced Sentinel Surveillance (ACCESS) was established with funding from the Department of Health and Ageing to trial the monitoring of the uptake and outcome of chlamydia testing in Australia. ACCESS involved 6 separate networks; 5 clinical networks involving sexual health services, family planning clinics, general practices, antenatal clinics, Aboriginal community controlled health services, and 1 laboratory network. The program ran from May 2007 to September 2010. An evaluation of ACCESS was undertaken in early 2010, 2 years after the program was funded. At the time of the evaluation, 76 of the 91 participating sites were contributing data. The jurisdictional distribution of the 76 sites generally matched the jurisdictional distribution of the Australian population. In 2008, the chlamydia testing rates in persons aged 16-29 years attending the 26 general practices was 4.2% in males and 7.0% in females. At the 25 sexual health services, the chlamydia testing rates in heterosexuals aged less than 25 years in 2008 was 77% in males and 74% in females. Between 2004 and 2008, the chlamydia positivity rate increased significantly in heterosexual females aged less than 25 years attending the sexual health services, from 11.5% to 14.1% (P < 0.01). Data completeness was above 85% for all core variables except Aboriginal and/or Torres Strait Islander status and country of birth, which ranged from 68%-100%, and 74%-100%, respectively, per network. There were delays in establishment of the system due to recruitment of 91 sites, multiple ethics applications and establishment of automated extraction programs in 10 different database systems, to transform clinic records into a common, pre-defined surveillance format. ACCESS has considerable potential as a mechanism toward supporting a better understanding of long-term trends in chlamydia notifications and to support policy and program delivery.

Entities:  

Mesh:

Year:  2010        PMID: 21090187

Source DB:  PubMed          Journal:  Commun Dis Intell Q Rep        ISSN: 1447-4514


  15 in total

1.  Testing-adjusted chlamydia notification trends in New South Wales, Australia, 2000 to 2010.

Authors:  Michelle Cretikos; Darren Mayne; Roderick Reynolds; Paula Spokes; Daniel Madeddu
Journal:  Western Pac Surveill Response J       Date:  2014-08-14

2.  High prevalence of sexual infection by human papillomavirus and Chlamydia trachomatis in sexually-active women from a large city in the Amazon region of Brazil.

Authors:  Leonardo Miranda Dos Santos; Josiellem Damasceno de Souza; Hilary Acha Mbakwa; Akim Felipe Santos Nobre; Rodrigo Covre Vieira; Stephen Francis Ferrari; Anderson Raiol Rodrigues; Edna Aoba Yassui Ishikawa; João Farias Guerreiro; Maísa Silva de Sousa
Journal:  PLoS One       Date:  2022-07-18       Impact factor: 3.752

3.  Anorectal swabs as a marker of male-to-male sexual exposure in STI surveillance systems.

Authors:  F H Ampt; C El Hayek; P A Agius; A L Bowring; N Bartnik; C VAN Gemert; C K Fairley; E P F Chow; C S Bradshaw; N Stephens; M S C Lim; M E Hellard
Journal:  Epidemiol Infect       Date:  2017-05-22       Impact factor: 4.434

4.  Public health policies and management strategies for genital Chlamydia trachomatis infection.

Authors:  Kelly Shaw; David Coleman; Maree O'Sullivan; Nicola Stephens
Journal:  Risk Manag Healthc Policy       Date:  2011-05-19

5.  Analysis of laboratory testing results collected in an enhanced chlamydia surveillance system in Australia, 2008-2010.

Authors:  Wayne Dimech; Megan S C Lim; Caroline Van Gemert; Rebecca Guy; Douglas Boyle; Basil Donovan; Margaret Hellard
Journal:  BMC Infect Dis       Date:  2014-06-12       Impact factor: 3.090

6.  Chlamydia among Australian Aboriginal and/or Torres Strait Islander people attending sexual health services, general practices and Aboriginal community controlled health services.

Authors:  James Ward; Jane Goller; Hammad Ali; Anna Bowring; Sophia Couzos; Mark Saunders; Phyllis Yau; John M Kaldor; Margaret Hellard; Rebecca J Guy; Basil Donovan
Journal:  BMC Health Serv Res       Date:  2014-07-01       Impact factor: 2.655

7.  Rationale and design of FORTH: a randomised controlled trial assessing the effectiveness of HIV self-testing in increasing HIV testing frequency among gay and bisexual men.

Authors:  Muhammad S Jamil; Garrett Prestage; Christopher K Fairley; Kirsty S Smith; John M Kaldor; Andrew E Grulich; Anna M McNulty; Marcus Chen; Martin Holt; Damian P Conway; Handan Wand; Phillip Keen; Colin Batrouney; Jack Bradley; Benjamin R Bavinton; Dermot Ryan; Darren Russell; Rebecca J Guy
Journal:  BMC Infect Dis       Date:  2015-12-10       Impact factor: 3.090

8.  Effectiveness of Implementation of Electronic Malaria Information System as the National Malaria Surveillance System in Thailand.

Authors:  Shaojin Ma; Saranath Lawpoolsri; Ngamphol Soonthornworasiri; Amnat Khamsiriwatchara; Kasemsak Jandee; Komchaluch Taweeseneepitch; Rungrawee Pawarana; Sukanya Jaiklaew; Boonchai Kijsanayotin; Jaranit Kaewkungwal
Journal:  JMIR Public Health Surveill       Date:  2016-05-06

9.  Expanded HIV pre-exposure prophylaxis (PrEP) implementation in communities in New South Wales, Australia (EPIC-NSW): design of an open label, single arm implementation trial.

Authors:  Iryna B Zablotska; Christine Selvey; Rebecca Guy; Karen Price; Jo Holden; Heather-Marie Schmidt; Anna McNulty; David Smith; Fengyi Jin; Janaki Amin; David A Cooper; Andrew E Grulich
Journal:  BMC Public Health       Date:  2018-02-02       Impact factor: 3.295

10.  Hepatitis C testing and re-testing among people attending sexual health services in Australia, and hepatitis C incidence among people with human immunodeficiency virus: analysis of national sentinel surveillance data.

Authors:  David C Boettiger; Matthew G Law; Gregory J Dore; Rebecca Guy; Denton Callander; Basil Donovan; Catherine C O'Connor; Christopher K Fairley; Margaret Hellard; Gail Matthews
Journal:  BMC Infect Dis       Date:  2017-12-01       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.